Cross Country Healthcare
Cross Country Healthcare
CCRN
NASDAQ
15.76
USD
0.00%
About
Cross Country Healthcare, Inc. is a technology-enabled workforce solution and advisory company. It operates through two segments: Nurse and Allied Staffing and Physician Staffing. The Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and allied professionals, and healthcare leaders within nursing, allied, physician, and human resources; vendor neutral programs and managed service programs (MSP); education healthcare services; in-home care services; and outsourcing services.
The Physician Staffing segment provides physicians in many specialties, as well as certified registered nurse anesthetists, nurse practitioners, and physician assistants as independent contractors on temporary assignments throughout the United States at various healthcare facilities, such as acute and non-acute care facilities, government facilities and managed care organizations..
Financials Amount (in millions)
Income statement
Balance sheet
Cash flow
Ratios
| Price and Volume | |
|---|---|
| Volume | |
| Ten Day Average Volume | 406.7K |
| Three Month Average Volume | 8.7M |
| High Low | |
| Fifty-Two Week High | 26.17 USD |
| Fifty-Two Week Low | 12.87 USD |
| Fifty-Two Week High Date | 01 Sep 2023 |
| Fifty-Two Week Low Date | 10 Jul 2024 |
| Price and Volume | |
| Current Price | 14.92 USD |
| Beta | 1 |
| Relative Price Change | |
| Four Week Relative Price Change | -17.46% |
| Thirteen Week Relative Price Change | -7.80% |
| Twenty-Six Week Relative Price Change | -26.33% |
| Fifty-Two Week Relative Price Change | -53.78% |
| Year-to-Date Relative Price Change | -44.35% |
| Price Change | |
| One Day Price Change | -1.26% |
| Thirteen Week Price Change | -1.32% |
| Twenty-Six Week Price Change | -19.00% |
| Five Day Price Change | -2.74% |
| Fifty-Two Week Price Change | -42.08% |
| Year-to-Date Price Change | -34.10% |
| Month-to-Date Price Change | -18.20% |
| Per Share Data | |
|---|---|
| Book Value | |
| Book Value Per Share (Last Fiscal Year) | 13.76746 USD |
| Book Value Per Share (Most Recent Quarter) | 13.15029 USD |
| Tangible Book Value Per Share (Last Fiscal Year) | 8.24475 USD |
| Tangible Book Value Per Share (Most Recent Quarter) | 7.62597 USD |
| EBITD | |
| EBITD Per Share (Trailing Twelve Months) | 1.40461 USD |
| Revenue | |
| Revenue Per Share (Last Fiscal Year) | 56.93224 USD |
| Revenue Per Share (Trailing Twelve Months) | 45.53234 USD |
| Dividend | |
| Dividend Per Share (Last Fiscal Year) | -99999.99 USD |
| Dividend Per Share (Trailing Twelve Months) | 0 USD |
| Dividend Per Share (5 Year) | -99999.99 USD |
| Earnings Per Share | |
| Excluding Extraordinary Items (Last Fiscal Year) | 2.04733 USD |
| Excluding Extraordinary Items (Trailing Twelve Months) | 0.2303 USD |
| Normalized (Last Fiscal Year) | 2.17027 USD |
| Basic Excluding Extraordinary Items (Last Fiscal Year) | 2.06585 USD |
| Basic Excluding Extraordinary Items (Trailing Twelve Months) | 0.23478 USD |
| Including Extraordinary Items (Last Fiscal Year) | 2.04733 USD |
| Including Extraordinary Items (Trailing Twelve Months) | 0.2303 USD |
| Cash | |
| Cash Per Share (Last Fiscal Year) | 0.49714 USD |
| Cash Per Share (Most Recent Quarter) | 2.08461 USD |
| Cash Flow Per Share (Last Fiscal Year) | 2.56449 USD |
| Cash Flow Per Share (Trailing Twelve Months) | 0.77649 USD |
| Free Cash Flow Per Share (Trailing Twelve Months) | 4.60847 USD |
| Margins | |
|---|---|
| Cash Flow Revenue | |
| Cash Flow Revenue (5 Year) | 4 |
| Cash Flow Revenue (Trailing Twelve Months) | 10 |
| Pretax Margin | |
| Pretax Margin (Trailing Twelve Months) | 1.05% |
| Pretax Margin (Last Fiscal Year) | 5.09% |
| Pretax Margin (5 Year) | 5.59% |
| Gross Margin | |
| Gross Margin (Last Fiscal Year) | 22.30% |
| Gross Margin (Trailing Twelve Months) | 21.33% |
| Gross Margin (5 Year) | 22.79% |
| Operating Margin | |
| Operating Margin (Last Fiscal Year) | 5.50% |
| Operating Margin (Trailing Twelve Months) | 1.11% |
| Operating Margin (5 Year) | 6.04% |
| Net Profit Margin | |
| Net Profit Margin (Last Fiscal Year) | 3.60% |
| Net Profit Margin (Trailing Twelve Months) | 0.54% |
| Net Profit Margin (5 Year) | 3.98% |
| Growth | |
|---|---|
| Book Value | |
| Book Value Per Share (5 Year) | 17.66% |
| Tangible Book Value (5 Year) | 47.30% |
| Free Operating Cash Flow | |
| Free Operating Cash Flow (5 Year) | 70.24% |
| Revenue | |
| Revenue Change MRQ vs 1 Year Ago | -37.16% |
| Revenue Growth (3 Year) | 19.86% |
| Revenue Change (Trailing Twelve Months) | -35.11% |
| Revenue Per Share Growth | 19.98% |
| Revenue Growth (5 Year) | 34.16% |
| Capital Spending Debt | |
| Capital Spending (5 Year) | 24.90% |
| Total Debt (5 Year) | -99,999.99% |
| Dividends | |
| Dividend Growth (3 Year) | -99,999.99% |
| Earnings Per Share | |
| EPS Change MRQ vs 1 Year Ago | -178.66% |
| EPS Change (Trailing Twelve Months) | -93.20% |
| EPS Growth (3 Year) | -99,999.99% |
| EPS Growth (5 Year) | -99,999.99% |
| EBITDA | |
| EBITDA (5 Year) | 37.95% |
| EBITDA (5 Year Interim) | 21.49% |
| Net Profit Margin | |
| Net Profit Margin Growth (5 Year) | -99,999.99% |
| Valuation | |
|---|---|
| Total Price to Book | |
| Price to Tangible Book (Last Fiscal Year) | 2 |
| Price to Tangible Book (Most Recent Quarter) | 2 |
| Price to Free Cash Flow | |
| Price to Free Cash Per Share (Last Fiscal Year) | 2 |
| Price to Free Cash Per Share (Trailing Twelve Months) | 3 |
| Net Debt | |
| Net Debt (Most Recent Quarter) | -69,601,000 |
| Net Debt (Last Fiscal Year) | -17,094,000 |
| Price to Sales | |
| Price to Sales (Last Fiscal Year) | 0 |
| Price to Sales (Trailing Twelve Months) | 0 |
| Price to Earnings | |
| PE Excluding Extraordinary Items (Last Fiscal Year) | 65 |
| PE Normalized (Last Fiscal Year) | 7 |
| PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | 59 |
| PE Excluding Extraordinary Items High (Trailing Twelve Months) | 60 |
| PE Excluding Extraordinary Items Low (Trailing Twelve Months) | 4 |
| PE Including Extraordinary Items (Trailing Twelve Months) | 65 |
| Dividends | |
| Dividend Yield (5 Year) | -99,999.99% |
| Dividend Yield | -99,999.99% |
| Current Dividend Yield | 0.00% |
| Price to Book | |
| Price to Book (Last Fiscal Year) | 1 |
| Price to Book (Most Recent Quarter) | 1 |
| Financial Strength | |
|---|---|
| Debt to Equity | |
| Long Term Debt to Equity (Last Fiscal Year) | 0 |
| Long Term Debt to Equity (Most Recent Quarter) | 0 |
| Payout Ratio | |
| Payout Ratio (Last Fiscal Year) | 0.00% |
| Payout Ratio (Trailing Twelve Months) | 0.00% |
| Quick Ratio | |
| Quick Ratio (Last Fiscal Year) | -100,000 |
| Quick Ratio (Most Recent Quarter) | -100,000 |
| Enterprise Value | |
| Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | 6 |
| Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | 28 |
| Current Ratio | |
| Current Ratio (Last Fiscal Year) | 3 |
| Current Ratio (Most Recent Quarter) | 3 |
| Free Cash Flow | |
| Free Cash Flow (Last Fiscal Year) | 234.5M |
| Free Cash Flow (Trailing Twelve Months) | 159.4M |
| Net Interest Coverage | |
| Net Interest Coverage (Last Fiscal Year) | 14 |
| Net Interest Coverage (Trailing Twelve Months) | 13 |
| Total Debt to Equity | |
| Total Debt to Equity (Last Fiscal Year) | 0 |
| Total Debt to Equity (Most Recent Quarter) | 0 |
| Management Effectiveness | |
|---|---|
| Return on Assets | |
| Return on Assets (Last Fiscal Year) | 8.93% |
| Return on Assets (Trailing Twelve Months) | 1.24% |
| Return on Assets (5 Year) | 10.93% |
| Return on Equity | |
| Return on Equity (Last Fiscal Year) | 15.61% |
| Return on Equity (Trailing Twelve Months) | 1.87% |
| Return on Equity (5 Year) | 22.75% |
| Return on Investment | |
| Return on Investment (Last Fiscal Year) | 12.04% |
| Return on Investment (Trailing Twelve Months) | 1.62% |
| Return on Investment (5 Year) | 14.75% |